Reuters -- Allergan Inc, maker of the Botox anti-wrinkle drug, reported higher fourth-quarter earnings on Thursday, but forecast a first-quarter profit below Wall Street estimates.
Reuters -- Allergan Inc, maker of the Botox anti-wrinkle drug, reported higher fourth-quarter earnings on Thursday, but forecast a first-quarter profit below Wall Street estimates.
